Salt Fund Gene Therapy, LP
What matters now
- +25%reported GAV
Reported gross assets rose from $13.2M to $16.4M between the Form ADV filings of 9 May 2024 and 30 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Amounts, each with its basis
- Vintage
- 2022basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $14.2Mwhat may be sold, not what was raised; file 021-448279, sworn by the adviser or filed under this vehicle
- Form D sold
- $14.2Mas of the filing of Jun 7, 2022, 43 investors
- First sale
- Feb 25, 2022
- Reported GAV
- $16.4Mon the Form ADV filed Mar 30, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 48
- Reported on ADV
- Mar 23, 2023 to Mar 30, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Lifecycle
Active deployment
Lifecycle
The fund's own reporting through time
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Venture Capital Fund | $13.2M | 44 | $10,000 | 0% | no | |
| Apr 11, 2023 | Venture Capital Fund | $13.2M | 44 | $10,000 | 0% | no | |
| Mar 20, 2024 | Venture Capital Fund | $13.2M | 44 | $10,000 | 0% | no | |
| May 9, 2024 | Venture Capital Fund | $13.2M | 44 | $10,000 | 0% | no | |
| Mar 30, 2026 | Venture Capital Fund | $16.4M | 48 | $10,000 | 0% |
Principals and agents
- LLC Salt Equity Partners I Director
Service providers
- AdministratorStandish Management · WALNUT CREEK, California, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
- CustodianSilicon Valley Bank · SANTA CLARA, California, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.Investments attributed to this vehicle
Timeline
- Mar 21, 2025Custodian changed: Silicon Valley Bank replaced First Republic Bank, first reported on the Form ADV filed March 21, 2025 (previous filing May 9, 2024)Custodian changed Fact Form ADV
- Mar 23, 2023Salt Fund Gene Therapy, LP first reported on Form ADV by Salt Fund Management LLC (Venture Capital Fund), GAV $13,156,006Fund first reported on Form ADV Fact Form ADV
- Jun 7, 2022SALT Fund Gene Therapy, LP filed Form D: $14,199,999 sold of $14,199,999, Venture Capital FundForm D filed Fact Form D
Evidence
Every observation on this vehicle
- Entity type: Limited Partnership Jun 7, 2022 Fact Form D
- Form D fund type: Venture Capital Fund Jun 7, 2022 Fact Form D
- Form D industry group: Pooled Investment Fund Jun 7, 2022 Fact Form D
- Amendment: false Jun 7, 2022 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 7, 2022 Fact Form D
- Incorporated: withinFiveYears Jun 7, 2022 Fact Form D
- Jurisdiction: Delaware Jun 7, 2022 Fact Form D
- Amount sold (Form D): $14.2M Jun 7, 2022 Fact Form D
- Offering amount (Form D): $14.2M Jun 7, 2022 Fact Form D
- Exemptions: 06b, 3C, 3C.1 Jun 7, 2022 Fact Form D
- First sale: 2022-02-25 Jun 7, 2022 Fact Form D
- Investors (Form D): 43 Jun 7, 2022 Fact Form D
- Minimum investment (Form D): 25,000 Jun 7, 2022 Fact Form D
- Securities offered: pooled Jun 7, 2022 Fact Form D
- Office address: Jun 7, 2022 Fact Form D
- Year of incorporation: 2022 Jun 7, 2022 Fact Form D
Relationships across DFX
on 1 other DFX graph
Salt Fund Gene Therapy, LP is the same institution as 1 record in RIA and Wealth.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Event retracted2026-10-01
- Fund first reported on ADV2023-03-23source on record
- Form D filed2022-06-07source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.